[1]
|
Bulun SE. Endometriosis[J]. N Engl J Med, 2009, 360: 268-279. doi: 10.1056/NEJMra0804690 |
[2]
|
Giudice LC. Clinical practice. Endometriosis[J]. N Engl J Med, 2010, 362: 2389-2398. doi: 10.1056/NEJMcp1000274 |
[3]
|
Young K, Fisher J, Kirkman M. Women's experiences of endometriosis: a systematic review and synthesis of qualitative research[J]. J Fam Plann Reprod Health Care, 2015, 41:225-234. doi: 10.1136/jfprhc-2013-100853 |
[4]
|
Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres[J]. Hum Reprod, 2012, 27: 1292-1299. doi: 10.1093/humrep/des073 |
[5]
|
Menakaya U, Infante F, Condous G. Consensus on current management of endometriosis[J]. Hum Reprod, 2013, 28: 3162-3163. doi: 10.1093/humrep/det346 |
[6]
|
Baranov VS, Ivaschenko TE, Liehr T, et al. Systems gene-tics view of endometriosis: a common complex disorder[J]. Eur J Obstet Gynecol Reprod Biol, 2015, 185C: 59-65. |
[7]
|
Fraser IS. Mysteries of endometriosis pain: Chien-Tien Hsu Memorial Lecture 2009[J]. J Obstet Gynaecol Res, 2010, 36: 1-10. doi: 10.1111/j.1447-0756.2010.01181.x |
[8]
|
Xu YQ, Jin SJ, Liu N, et al. Aloperine attenuated neuropathic pain induced by chronic constriction injury via anti-oxidation activity and suppression of the nuclear factor kappa B pathway[J]. Biochem Biophys Res Commun, 2014, 451: 568-573. doi: 10.1016/j.bbrc.2014.08.025 |
[9]
|
Gonzalez-Ramos R, Defrere S, Devoto L. Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology[J]. Fertil Steril, 2012, 98: 520-528. doi: 10.1016/j.fertnstert.2012.06.021 |
[10]
|
Gonzalez-Ramos R, Van Langendonckt A, Defrere S, et al. Involvement of the nuclear factor-kappaB pathway in the pathogenesis of endometriosis[J]. Fertil Steril, 2010, 94: 1985-1994. doi: 10.1016/j.fertnstert.2010.01.013 |
[11]
|
Maia H, Jr Haddad C, Coelho G, et al. Role of inflammation and aromatase expression in the eutopic endometrium and its relationship with the development of endometriosis[J]. Womens Health (Lond), 2012, 8: 647-658. doi: 10.2217/WHE.12.52 |
[12]
|
González-Ramos R, Donnez J, Defrère S, et al. Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis[J]. Mol Hum Reprod, 2007, 13: 503-509. doi: 10.1093/molehr/gam033 |
[13]
|
Alvarado-Diaz CP, Nunez MT, Devoto L, et al. Iron overload-modulated nuclear factor kappa-B activation in human endometrial stromal cells as a mechanism postulated in endometriosis pathogenesis[J]. Fertil Steril, 2015, 103: 439-447. doi: 10.1016/j.fertnstert.2014.10.046 |
[14]
|
Park H, Kim SH, Cho YM, et al. Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis[J]. Obstet Gynecol Sci, 2016, 59: 123-129. doi: 10.5468/ogs.2016.59.2.123 |
[15]
|
Alvarez P, Levine JD. Screening the role of pronociceptive molecules in a rodent model of endometriosis pain[J]. J Pain, 2014, 15: 726-733. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=a9a5458ea3ecf179d83caaba8167df14 |
[16]
|
Yun BH, Chon SJ, Choi YS, et al. Pathophysiology of Endometriosis: Role of High Mobility Group Box-1 and Toll-Like Receptor 4 Developing Inflammation in Endometrium[J]. PLoS One, 2016, 11: e0148165. doi: 10.1371/journal.pone.0148165 |
[17]
|
Luo JG, Zhao XL, Xu WC, et al. Activation of spinal NF-kappaB/p65 contributes to peripheral inflammation and hyperalgesia in rat adjuvant-induced arthritis[J]. Arthritis Rheumatol, 2014, 66: 896-906. doi: 10.1002/art.38328 |
[18]
|
Kaltschmidt B, Kaltschmidt C. NF-kappaB in the nervous system[J]. Cold Spring Harb Perspect Biol, 2009, 1: a001271. |
[19]
|
Bajaj P, Madsen H, Arendt-Nielsen L. Endometriosis is associated with central sensitization: a psychophysical controlled study[J]. J Pain, 2003, 4: 372-380. doi: 10.1016/S1526-5900(03)00720-X |
[20]
|
Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs[J]. Genome Res, 2009, 19: 92-105. http://ard.bmj.com/cgi/ijlink?linkType=ABST&journalCode=genome&resid=19/1/92 |
[21]
|
Andersen HH, Duroux M, Gazerani P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions[J]. Neurobiol Dis, 2014, 71: 159-168. doi: 10.1016/j.nbd.2014.08.003 |
[22]
|
Suryawanshi S, Vlad AM, Lin HM, et al. Plasma micro-RNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer[J]. Clin Cancer Res, 2013, 19: 1213-1224. doi: 10.1158/1078-0432.CCR-12-2726 |
[23]
|
Hawkins SM, Creighton CJ, Han DY, et al. Functional microRNA involved in endometriosis[J]. Mol Endocrinol, 2011, 25: 821-832. doi: 10.1210/me.2010-0371 |
[24]
|
Borghese B, Zondervan KT, Abrao MS, et al. Recent insights on the genetics and epigenetics of endometriosis[J]. Clin Genet, 2016.doi: 10.1111/cge.12897.[Epub ahead of print] |
[25]
|
Niederberger E, Kynast K, Lotsch J, et al. MicroRNAs as new players in the pain game[J]. Pain, 2011, 152: 1455-1458. doi: 10.1016/j.pain.2011.01.042 |
[26]
|
Kress M, Huttenhofer A, Landry M, et al. microRNAs in nociceptive circuits as predictors of future clinical applications[J]. Front Mol Neurosci, 2013, 6: 33. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Doaj000003586398 |
[27]
|
Ma X, Becker Buscaglia LE, Barker JR, et al. MicroRNAs in NF-kappa B signaling[J]. J Mol Cell Biol, 2011, 3: 159-166. doi: 10.1093/jmcb/mjr007 |